Connect with us

Technology

WELL Health Announces Approval for Historic $44M Project, the Largest DIGITAL Project Ever Awarded to Advance AI-powered Tech Enablement for Care Providers

Published

on

WELL Health and its consortium partners have been awarded the largest DIGITAL project to date for Health Compass II, an initiative that will continue the advancement of AI and interoperability in Canadian healthcare.WELL Health will not only serve as the lead commercialization partner and first customer, but will also provide expertise and interoperability to each consortium partner for an unprecedented opportunity to innovate and develop new AI tools to better support and enable healthcare providers to enhance patient outcomes.As part of the approval, DIGITAL will fund just over one third of all project costs related to this project over a period of 4 years. These funds are appropriated by the Federal Government of Canada to support technology innovation.

VANCOUVER, BC and TORONTO, July 10, 2024 /PRNewswire/ – WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the “Company” or “WELL”), a leading company focused on consolidating and modernizing clinical and digital assets within the healthcare sector, is thrilled to announce the approval and advancement of a groundbreaking $44M project, which will receive $15.3M in funding from DIGITAL to support investments in R&D and commercialization from other partners for phase 2 of the Health Compass project, known as Health Compass II. This monumental funding represents the largest project DIGITAL, Canada’s Global Innovation Cluster for digital technologies, has awarded to date in any funding category, marking a significant milestone in the commitment and advancement of AI and interoperability in healthcare.

Health Compass II, a collaborative effort with WELL Health, ORX, HEALWELL AI (TSX: AIDX, OTCQX: HWAIF), Tali AI, Phelix, and Simon Fraser University driving critical contributions. Health Compass II aims to further revolutionize the healthcare industry by enhancing interoperability and leveraging AI to reduce healthcare provider burdens. Building on the success of the initial Health Compass phase, Health Compass II will introduce an innovative suite of four AI-driven modules integrated through an EMR-agnostic mobile app, designed to engage patients, automate administrative tasks, assist healthcare providers with documentation, and enhance clinical decision-making.

The project’s components include:

Decision Compass by HEALWELL AI: A clinical decision support module to identify opportunities for earlier diagnosis and/or improved care for rare and complex diseases.Patient Compass by ORX: A user-friendly patient-facing virtual agent module that improves patient engagement by 30% by enabling patients to find, get and advance care with providers.SMART Inbox by Phelix: A back-of-house automation module that leverages AI algorithms to streamline administrative tasks and reduce manual administrative efforts for clinics by 50% or more.Voice Assistant by Tali: An AI Assistant that employs ambient sensing technology to capture medically relevant information from natural conversations, with patient consent, without taking provider focus away from their patient.

The combination of all four Health Compass II partner AI modules into WELL’s Provider Compass will result in equipping healthcare providers with the automation of all non-billable patient interactions and outputs of the patient visit (patient referral letters, prescriptions, etc.); scribe the entirety of the provider-patient visit; and provide clinical suggestions based on the patient’s medical record. Ultimately, enabling a reality for clinics and clinicians to focus more on patient care by automating the majority of day-to-day administrative tasks without having to turn on their computer.

Hamed Shahbazi, CEO and Founder of WELL, shared his excitement and gratitude about this announcement: “This is a monumental milestone and we are honoured and grateful to DIGITAL and Minister Champagne’s office for their commitment to supporting healthcare innovation and responsible AI research. At WELL, we are committed to leveraging technology to empower healthcare providers and reduce burnout by equipping them with responsible AI and other tools to assist in providing quality care and ultimately improve patient outcomes. Projects like Health Compass II directly support this mission and are essential in fuelling healthcare’s digital transformation.”

The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry shared, “artificial intelligence presents a transformative opportunity for healthcare professionals to innovate and enhance patient experiences, and Canada is at the forefront of this pivotal field. Our government is proud to champion the Digital Technology Cluster as it collaborates with industry partners, like WELL Health, to reshape the delivery of healthcare services for Canadians.”

Taleeb Noormohamed, Parliamentary Secretary to the Minister of Canadian Heritage shared, “from helping health professionals take notes and assist in recording their diagnoses, to streamlining administrative paperwork and facilitating the patient care experience, this innovative project is using AI to build a better future for Canadians. The government looks forward to the success of the Health Compass II project and to other made-in-Canada innovations, that will unlock social and economic benefits for everyone.”

Canada has a significant opportunity and imperative to leverage our global leadership in AI research into accelerated commercialization of that research into Canadian AI applications and tools. These tools will help solve some of the world’s biggest challenges while accelerating the growth of Canadian companies. DIGITAL’s continued investment in the Health Compass initiative is supporting improved health outcomes for Canadians while also supporting Canadian innovators,” said Sue Paish, CEO of DIGITAL. “Since 2018, DIGITAL has worked to foster innovation, help Canadian companies grow and spur private sector investment in digital solutions that are making a positive difference in the lives of Canadians.”

Health Compass II is set to transform the way healthcare providers practice by replacing traditional exam room workstations with a clinician’s preferred smartphone device, automating the majority of day-to-day tasks without the need for a computer. This initiative is expected to achieve a 25% reduction in healthcare delivery costs for clinics and a 20% improvement in patient satisfaction within the first two years post-implementation.

WELL Health will not only serve as the lead commercialization partner and first customer, but will also be continuing to build standards-based API interoperability, giving a competitive advantage to each SME AI module developed. The consortium will leverage WELL’s extensive network, including their Provider Solutions platform that supports more than 3,400 clinics and over 34,000 healthcare providers, including the distribution channels of OceanMD (A WELL Health Company) and its’ EMR assets, as well as WELL’s own clinic network across Canada that includes over 175 clinics and greater than 1,600 healthcare providers including registered physicians and other healthcare professionals. WELL’s Provider Solutions Platform is Canada’s leader in healthcare provider products and services, AI healthcare solutions, and information security services, WELL is committed to ensuring that best-in-class privacy, cyber security and ethical AI implementation remains at the forefront of the commercialization of Health Compass II.

The Health Compass II project is a testament to WELL Health’s commitment to empowering healthcare providers and enhancing patient experiences across North America. With this significant investment, WELL Health and its partners are poised to set a new standard for the deployment of ethical AI in healthcare, interoperability and EMR innovation, healthcare provider workflows, and patient care. Health Compass II and other healthcare innovations from WELL and its partners, will undoubtedly contribute towards the improvement of health outcomes for Canadians and the reduction of healthcare provider burnout.

About WELL Health Technologies Corp.

WELL’s mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL’s comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. WELL’s solutions enable more than 34,000 healthcare providers between the US and Canada and power the largest owned and operated healthcare ecosystem in Canada with more than 175 clinics supporting primary care, specialized care, and diagnostic services. In the United States WELL’s solutions are focused on specialized markets such as the gastrointestinal market, women’s health, primary care, and mental health. WELL is publicly traded on the Toronto Stock Exchange under the symbol “WELL” and on the OTC Exchange under the symbol “WHTCF”. To learn more about WELL, please visit: www.well.company.

Forward-Looking Statements

This press release may contain “forward-looking statements” within the meaning of applicable Canadian securities laws, including, without limitation, statements regarding the future plans and objectives of WELL Health, the capabilities of Health Compass II, and future funding commitments from DIGITAL. Forward-looking statements are statements that are not historical facts and are generally, although not always, identified by words such as “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” “potential,” and similar expressions, or that events or conditions “will,” “would,” “may,” “could,” or “should” occur. While these forward-looking statements represent WELL Health’s current expectations, they are subject to a number of risks and uncertainties that could cause actual results to differ materially, such as the ability to develop and commercialize the Health Compass II amongst the consortium members, the expected improvements to workflow efficiency, physician uptake, and the utilization and deployment of the Health Compass II across WELL Health’s network. WELL Health does not undertake to update any forward-looking statements, except in accordance with applicable securities laws.

View original content to download multimedia:https://www.prnewswire.com/news-releases/well-health-announces-approval-for-historic-44m-project-the-largest-digital-project-ever-awarded-to-advance-ai-powered-tech-enablement-for-care-providers-302193793.html

SOURCE WELL Health Technologies Corp.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Evermos Partners with the International Labour Organisation (ILO) to Deliver Entrepreneurship Training for Indonesia’s Vulnerable Groups

Published

on

By

BANDUNG, Indonesia, June 19, 2026 /PRNewswire/ — Evermos, a Bandung-based reseller platform focused on MSME empowerment, sees significant potential for vulnerable groups to achieve economic empowerment through digital business. According to Statistics Indonesia (BPS), the labour force participation rate among persons with disabilities stood at only around 20% in early 2025, far behind the roughly 70% recorded among people without disabilities.

“We see digital business as a bridge to lower the barriers to economic access for persons with disabilities and returning migrant workers. No significant capital, no need for a physical location, a mobile phone is enough. This business model opens up the opportunity for them to build an independent and sustainable source of income.”
Iqbal Muslimin, Chief of Sustainability, Evermos

The collaboration runs under the ILO project Promise II Impact, which aims to improve MSMEs’ access to financial services and has been running since 2023. It aligns with Evermos’ vision of advancing MSME empowerment across Indonesia. Evermos provides the digital business ecosystem, from its reseller platform and curated halal products to business training and mentoring, while the ILO brings a decent work framework and financial literacy modules that help participants start digital businesses on sound financial footing.

Since 2023, more than 230 beneficiaries have felt the project’s impact across various cities. In March 2026, Evermos and the ILO, together with the Migrant Worker Resource Centre (MRC), delivered digital entrepreneurship training for migrant workers in Cirebon, West Java. A similar programme was also held in the Special Region of Yogyakarta, involving persons with disabilities from various groups, including those supported by the BPKK of the Indonesian Ministry of Manpower, the Indonesian Association of Women with Disabilities (HWDI) Sleman, and the Mitra Sejahtera Disability Empowerment Centre (PPDMS) Gunungkidul.

During the training, participants were guided to try selecting products to sell directly through the Evermos app, to apply digital marketing techniques, and to strengthen their entrepreneurial mindset so that earnings from their working years can grow into long-term productive assets. They were also introduced to and practised using WhatsApp Business as one tool to start a digital business. Meanwhile, the ILO team complemented the training with basic financial literacy so participants could manage their new businesses soundly.

“For us, digital transformation also becomes meaningful when it reaches vulnerable groups, those furthest from the information they need to empower themselves economically. Through Evermos, a person with a disability or a migrant worker returning to their hometown can start a business with nothing more than a smartphone, without significant capital — and that is what truly inclusive empowerment looks like.”
Arip Tirta, President, Evermos

“The conclusion of this series of activities is not the end of the participants’ journey, but the beginning of their path as digital entrepreneurs. Three years of experience have shown that when vulnerable groups gain access to the right skills, technology, and mentoring, they are able to create economic opportunities for themselves. The partnership between the ILO and Evermos is an example of how collaboration can help bring about more inclusive economic growth that leaves no one behind.”
Djauhari Sitorus, Project Manager, Promise II Impact

Closing out three years of the Promise II Impact project, Evermos and the ILO hope this contribution can encourage vulnerable groups to take part in driving Indonesia’s economic growth as digital entrepreneurs. By opening access to doing business digitally, vulnerable groups can become economically empowered and self-reliant. Beyond that, the collaboration is intended to serve as a model of inclusive empowerment that can be replicated across more regions — so that an economy open to all is not merely an aspiration, but something that can be realised.

About Evermos

Evermos is a reseller platform that integrates a distribution network, commerce services, and a curated range of halal products with business communities focused on serving underserved communities. Evermos supports the success of its resellers regardless of gender, educational background, or geographic location by providing regular business training and mentoring.

Founded in November 2018, Evermos has built the largest reseller-based connected commerce network in Indonesia, with over 1 million resellers nationwide, more than 200,000 active monthly sellers, and hundreds of products from Indonesian MSMEs. Evermos has also received various prestigious accolades, including the Top CSR Award – Star 4 2026, the Seal Business Sustainability Award 2025, the Nikkei Asia Award 2023, and the UN Women 2024 Indonesian Women’s Empowerment Principles (WEPs), and is a member of the global Endeavor Entrepreneur network. Evermos is also part of the World Economic Forum’s Global Innovators Community.

View original content to download multimedia:https://www.prnewswire.com/news-releases/evermos-partners-with-the-international-labour-organisation-ilo-to-deliver-entrepreneurship-training-for-indonesias-vulnerable-groups-302805209.html

SOURCE Evermos

Continue Reading

Technology

Innovid by Mediaocean Positioned as a Leader in the SPARK Matrix™: AdTech Platform, 2026 by QKS Group

Published

on

By

PUNE, India, June 19, 2026 /PRNewswire/ — QKS Group announced today that it has named Innovid by Mediaocean as a leader in the SPARK Matrix™: AdTech Platform, 2026. This comprehensive evaluation provides a detailed competitive analysis, market ranking, and strategic insights to help users evaluate global vendor capabilities and market positions.

This recognition also reflects Innovid’s continued investment in AI-powered execution and the value it is delivering to customers and the industry at large. Earlier this month, the company introduced NIVO, its AI core for agents and orchestration, helping marketers turn intelligence into action across the advertising lifecycle. Early adopters have already reported workflow efficiency gains of up to 90%. 

“Innovid by Mediaocean’s leadership position in the advertising technology market is supported by its breadth across creative management, ad serving, campaign execution, measurement, optimization, and workflow automation,” said Richa Choubey, Senior Analyst, QKS Group. “The platform is particularly strong in helping advertisers manage campaigns across connected TV, digital, social, and linear media while providing greater consistency in execution and measurement across channels. Through cross-channel delivery capabilities, independent measurement, AI-enabled optimization, and interoperability across the advertising ecosystem, Innovid by Mediaocean enables brands and agencies to improve operational efficiency, strengthen performance visibility, and better manage increasingly fragmented media environments. Its integrated approach supports organizations seeking greater control over campaign operations, measurement consistency, and linkage between advertising investments and business outcomes.”

Analyst Assessment: Aligning with Market Dynamics

Innovid operates at the intersection of several of the most significant trends shaping the advertising technology landscape, including the rise of CTV, the growing demand for independent measurement, increasing media fragmentation, and the application of AI to campaign execution and optimization. Rather than competing solely on individual point capabilities, the platform’s value proposition lies in its ability to connect creative management, ad serving, measurement, and optimization workflows across channels that have traditionally been managed in silos.

As advertisers navigate an increasingly complex ecosystem characterized by evolving privacy requirements, proliferating media environments, and heightened expectations for accountability, platforms that can provide consistency, interoperability, and operational efficiency become increasingly important. Innovid’s continued investments in cross-channel measurement, CTV innovation, and AI-enabled workflow automation reflect a clear understanding of these market dynamics. While the AdTech market remains highly competitive and rapidly evolving, Innovid has established itself as a significant independent player with a differentiated position in helping brands, agencies, and media organizations execute, measure, and optimize campaigns across fragmented digital and television environments. Its ability to balance scale, openness, and innovation positions it well as organizations seek greater transparency and control over advertising performance in an omnichannel world.

“Innovid demonstrates differentiated capabilities in creative management and optimization, leveraging AI and automation to improve campaign efficiency and effectiveness,” said Umang Thakur, Vice President and Principal Analyst, QKS Group. “Its support for omnichannel activation, unified measurement, and cross-platform creative governance makes it well suited for organizations seeking to centralize advertising operations and maximize the impact of creative assets at scale.”

Building on a Foundation of AI Innovation

In 2025, QKS Group named Innovid the ‘Most Valuable Pioneer‘ in its AI Maturity Matrix for AdTech, highlighting the company’s ability to embed intelligence across the campaign lifecycle. With the launch of NIVO AI, Innovid has evolved that embedded intelligence into live, scalable execution, addressing the multi-channel complexities and fragmentation challenges highlighted in the QKS report.

“What stands out in this report is the growing need for greater connectivity across the advertising ecosystem,” said Grant Parker, President, Innovid. “Marketers aren’t struggling with a lack of tools; they’re struggling with disconnected workflows, fragmented data, and operational complexity. With NIVO, we’re helping brands and agencies bring those workflows together, turning signals into coordinated action across creative, delivery, measurement, and optimization.”

Access the Report

To download the full report and explore the visit SPARK Matrix™: AdTech Platform, 2026.

About Innovid

Innovid is the leading omnichannel advertising platform, empowering marketers to create, deliver, measure, and optimize ad-supported experiences. At the core of Innovid is NIVO, powering AI agents and orchestration to activate, adapt, and optimize campaigns across the advertising lifecycle. As part of Mediaocean, Innovid is tied into Prisma, the industry’s core ad infrastructure for planning, buying, and billing, as well as Protected for verification, fraud detection, and brand safety. Visit www.innovid.com to learn more.

Media Contact:
Megan Coyle
Megan@innovid.com

About QKS Group

QKS Group is a global analyst and advisory firm helping enterprises, technology vendors, and investors make trusted, data-driven decisions. Our portfolio spans the flagship SPARK Matrix™ evaluation framework, SPARK Plus™ analyst advisory platform, QKS Intelligence™ for market and competitive tracking, and QKS Community™ for CXO leaders and practitioners. All offerings are powered by a Human-Intelligence-driven framework and QKS’s closed-loop research methodology–integrating expert-led insights, quantitative modeling, and continuous validation to deliver credible, outcome-focused intelligence. For more available research, please visit Research.

Media Contact:
Anish
PR & Media Relations
QKS Group 
5th Floor, Wing 2, Cluster C, 
EON Free Zone, Kharadi,
Pune, India
Email: support@qksgroup.com
Content Source: https://qksgroup.com/newsroom/innovid-by-mediaocean-positioned-as-a-leader-in-the-spark-matrix-adtech-platform-2026-by-qks-group-1699 
Connect with us on LinkedIn- https://www.linkedin.com/company/qksgroup/

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/innovid-by-mediaocean-positioned-as-a-leader-in-the-spark-matrix-adtech-platform-2026-by-qks-group-302805199.html

Continue Reading

Technology

Innoscience’s current products are not affected by both rulings of the Munich Regional Court

Published

on

By

MUNICH, June 18, 2026 /PRNewswire/ — Innoscience today announced that the Munich Regional Court has just issued a pair of rulings, from which it could be confirmed that Innoscience’s currently marketed gallium nitride (“GaN”) power device products fall outside the scope of Infineon’s asserted German patents and may be commercialized in Germany without restriction.

These rulings are fully consistent with the final determination issued last month by the U.S. International Trade Commission (“ITC”), which found that Innoscience’s current products do not infringe Infineon’s asserted U.S. patent relating to packaging design (U.S. Patent No. 9,899,481). The Munich case concerns the German counterparts of that same patent family. In line with the ITC’s findings, the Munich Court found infringement only with respect to a limited set of legacy products—certain packaged 650–700V transistors—that had already been discontinued. Therefore, any injunction granted would not apply to Innoscience’s current product portfolio. As a result, there is no impact on Innoscience’s ongoing operations or its customers’ use of its products in Germany.

The decisions mark another significant milestone in Innoscience’s string of favorable outcomes across major jurisdictions. They follow the company’s recent success in China, where it secured an injunction and damages award against Infineon, as well as its decisive victory at the ITC in the United States last month. Together, these rulings reaffirm the legality of Innoscience’s current product portfolio and its ability to operate freely in key global markets.

While proceedings in Germany remain ongoing, including Innoscience’s invalidity challenges to the asserted German patent, the growing body of decisions across China, the United States, and Germany underscores that the global litigation campaign initiated by Infineon has not altered the competitive position of Innoscience’s core products. To the contrary, independent judicial findings across multiple jurisdictions have consistently validated the robustness of Innoscience’s technology and reinforced market confidence in the company’s product compliance and innovation capabilities.

Innoscience remains committed to advancing its technology leadership and expanding its global footprint, delivering cutting-edge GaN solutions to customers worldwide in a fair and competitive marketplace.

View original content:https://www.prnewswire.com/news-releases/innosciences-current-products-are-not-affected-by-both-rulings-of-the-munich-regional-court-302805093.html

SOURCE InnoScience

Continue Reading

Trending